Chemopreventive effects of Elm tree root extract on colonic aberrant crypt foci induced by 1,2-dimethylhydrazine in F344 rats

Journal of Food Science and Nutrition

Volumn 13, Issue 3, 2008, Pages 157-165

  Kwon, Hyun Jung ^a   Kim, Tae Myoung ^a   Ryu, Jae Myun ^a   Son, Seung Hwan ^a   Hong, Jin Tae ^a   Jeong, Heon Sang ^a   Kang, Jin Seok ^b   Ahn, Ji Yun ^c   Kim, Sung Ran ^c   Ha, Tae Youl ^c   Kim, Dae Joong ^a  

^a Chungbuk National University   (South Korea)

^b Namseoul University   (South Korea)

^c Korea Food Research Institute   (South Korea)

Author keywords

Aberrant crypt foci (ACF); Apoptosis; Caspase 3; Colon cancer; Elm tree root

Indexed keywords

RATTUS; ULMUS;

EID: 84860751616     PISSN: 1226332X     EISSN: None     Source Type: Journal    
DOI: 10.3746/jfn.2008.13.3.157     Document Type: Article

References (62)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. 2005. Cancer statistics. CA Cancer J Clin 55: 10-30.
2. Vital Statistics Division. 2004. Annual Report on the Cause of Death Statistics, Korea National Statistical Office, Seoul.
3. Reddy BS. 2000. The Fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol Biomarkers Prev 9: 239-247. (Pubitemid 30165435)
4. Newmark HL, Lipkim M, Kopelovich L, Liu Y, Fan K, Shinozaki H. 2001. A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis 22: 1871-1875. (Pubitemid 33064854)
5. Gupta RA, Dubois RN. 2001. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1: 11-21. (Pubitemid 33741877)
6. Johnson IT. 2002. Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. Food Chem Toxicol 40: 1171-1178. (Pubitemid 34626882)
7. Potten CS. 2002. Apoptosis induced in small intestinal crypts by low doses of radiation protects the epithelium from genotoxic damage. Int Congr Ser 1236: 407-413.
8. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
9. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakumura Y, White R, Smits AMM, Bos JL. 1988. Genetic alterations during colorectal tumor development. N Engl J Med 319: 525-532.
10. Weisburger JH. 1971. Colon carcinogens: their metabolism and mode of action. Cancer 28: 60-70.
11. Ward JM. 1974. Morphogenesis of chemically induced neoplasm of the colon and small intestine in rats. Lab Invest 30: 505-513.
12. Brady JF, Li D, Ishizaki H, Yang CS. 1988. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Cancer Res 48: 5937-5940. (Pubitemid 18266779)
13. Bird RP. 1987. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37: 147-151. (Pubitemid 17157833)
14. Bird RP. 1995. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93: 55-71.
15. Bird RP. 1991. Effect of cholic acid on the number and growth of aberrant crypt foci: putative preneoplastic lesions. Proc Am Assoc Cancer Res 32: 76-81.
16. Archer MC, Bruce WR, Chan CC, Corpet DF, Medline A, Roncucci I, Stamp D, Zhand XM. 1992. Aberrant crypt foci and microadenoma as marker for colon cancer. Envion Health Perspect 98: 195-197. (Pubitemid 23061804)
17. Bird RP. 1995. Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon. Cancer Lett 88: 201-209.
18. Bird RP, McLellan EA, Bruce WR. 1989. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv 8: 189-200. (Pubitemid 20041145)
19. Bird RP, Pretlow TP. 1992. Letter to the Editor. Cancer Res 52: 4291-4292.
20. Pereira MA, Barnes LH, Rassman VL, Kelloff GV, Steele VE. 1994. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15: 1049-1054. (Pubitemid 24156909)
21. Wattenberg LW. 1997. An overview of chemoprevention: current status and future prospects. Proc Soc Exp Biol Med 216: 133-141.
22. Greenwald P, Milner JA, Anderson DE, McDonald SS. 2002. Micronutrients in cancer chemoprevention. Cancer Metastasis Rev 21: 217-230. (Pubitemid 36071911)
23. Tanaka T, Kohno H, Mori H. 2001. Chemoprevention of colon carcinogenesis by dietary non-nutrientive compounds. Asian Pac J Cancer Prev 2: 165-177.
24. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malon WA, Boone CW, Kopelovich L, Hawk ET, Liberman R, Lawrence JA, Ali I, Viner JL, Sigman CC. 2000. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 130: 467-471.
25. Lee SJ. 1966. Korean Folk Medicine Monographs Series No. 3. Seoul National University Press, Seoul. p 39.
26. Jun CD, Pae HO, Kim YC, Jeong SJ, Yoo JC, Lee EJ, Choi BM, Chae SW, Park RK, Chung HT. 1998. Inhibition of nitric oxide synthesis by butanol fraction of the methanol extract of Ulmus davidiana in murine macrophages. J Ethnopharmacol 62: 129-135.
27. Lim KT, Chun H, Kitts DD. 2001. Anti-oxidant activity of a Rhus verniciflua Stokes ethanol extract. Food Chem Toxicol 39: 229-237. (Pubitemid 32244130)
28. Lee JC, Lim KT. 2001. Inhibitory effects of the ethanol extract of Ulmus Davidiana on apoptosis induced by glucose- glucose oxidase and cytokine production in cultured mouse primary immune cells. J Biochem Mol Biol 34: 463-471.
29. Kim HK, Lim YM, Kim DK, Nho YC. 2008. Effect of natural extracts mixture from Houttuynia cerdata and Ulmus davidiana var. japonica in mast cell-induced allergic inflammatory response. Lab Anim Res 24: 1-7.
30. Eun JS, Song WY. 1994. The combined effects of n-BuOH fraction of ulmi cortex and anticancer drugs on cancer cell lines. Kor J Pharmacogn 25: 144-152. (Pubitemid 24192745)
31. Sengupta A, Shosh S, Das S. 2004. Modulatory influence of garlic and tomato on cyclooxygenase-2 activity, cell proliferation and apoptosis during azoxymethane induced colon carcinogenesis in rat. Cancer Lett 208: 127-136. (Pubitemid 38624153)
32. Volate SR, Davenport DM, Muga SJ, Wargovich MJ. 2005. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26: 1450-1456. (Pubitemid 41417889)
33. Moon YH, Rim GR. 1995. Studies on the constituents of Ulmus parvifolia. Kor J Pharmacogn 26: 1-7.
34. Kim SH, Hwang KT, Park JC. 1992. Isolation of flavonoids and determination of rutin from the leaves of Ulmus parviflora. Kor J Pharmacogn 23: 229-233. (Pubitemid 23155173)
35. Yang YL, Kim YJ. 2001. Immunostimulating exopolysaccharide with anticancer activity from Enterobacter sp. SSY (KCTC 0687BP) screened from Ulmus parvifolia. Kor J Biotechnol Bioeng 16: 554-561.
36. Lee SJ, Heo KS, OH PS, Lim K, Lim KT. 2004. Glycoprotein isolated from Ulmus davidiana Nakai inhibits TPA-induced apoptosis through nuclear factor-kappa B in NIH/3T3 cells. Toxicol Lett 146: 159-174. (Pubitemid 37487830)
37. Ko JH, Lee SJ, Lim KT. 2005. 116 kDa glycoprotein isolated from Ulmus davidiana Nakai (UDN) inhibits glucose/ glucose oxidase (G/GO)-induced apoptosis in BNL CL.2 cells. J Enthnopharmacol 100: 339-346.
38. Lee JC, Lee KY, Son YO, Choi KC, Kim J, Truong TT, Jang YS. 2005. Plant-originated glycoprotein, G-120, inhibits the growth of MCF-7 cells and induces their apoptosis. Food Chem Toxicol 43: 961-968. (Pubitemid 40462074)
39. Son YO, Lee KY, Choi KC, Chung Y, Kim JG, Jeon YM, Jang YS, Lee JC. 2004. Inhibitory effects of glycoprotein- 120 (G-120) from Ulmus davidiana Nakai on cell growth and activation of matrix metalloproteinases. Mol Cells 18: 163-170. (Pubitemid 40081209)
40. Choi WH, Oh YS, Ahn JW, Kim SR, Ha TY. 2005. Antioxidative and protective effects of Ulmus davidiana var. japonica extracts on glutamate-induced cytotoxicity in PC 12 Cells. Kor J Food Sci Technol 37: 479-483. (Pubitemid 41085735)
41. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, Stellato TA, 1991. Aberrant crypt: putative preneoplastic foci in human colonic mucosa. Cancer Res 51: 1564-1567.
42. Pretlow TP, Roukhadze EV, O'Riordan MA, Chan JC, Amini SB, Stellato TA. 1994. Carcinoembryonic antigenin human colonic aberrant crypt foci. Gastroenterology 107: 1719-1725. (Pubitemid 24357625)
43. Roncucci L, Pedroni M, Fante R, Di Gregorio C, Ponz de Leon M. 1993. Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy). Cancer Res 53: 3726-3729. (Pubitemid 23252033)
44. Dashwood RH, Xu M, Orner GA, Horio DT. 2001. Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2-amino-3- methylimidaz. Eur J Cancer Prev 10: 139-145.
45. McLellan EA, Medline A, Bird RP. 1991. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis 12: 2093-2098.
46. Siu IM, Robinson DR, Schwartz S, Kung HJ, Pretlow TG, Petersen RB, Pretlow TP. 1999. The identification of monoclonality in human aberrant crypt foci. Cancer Res 59: 63-66. (Pubitemid 29062957)
47. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43.
48. Fernandes AT, Litwack G, Alnemri ES. 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269: 30761-30764. (Pubitemid 24377553)
49. Bae MA, Yamada K, Uemura D, Seu JH, Kim YH. 1998. Aburnatubolactam C, a novel apoptosis-inducing substance produced by murine Streptomyces sp. SCRC A-20. J Microbiol Biotechnol 8: 455-460. (Pubitemid 28551570)
50. Dove A. 2001. Making a living out of the art of dying. Nat Biotechnol 19: 615-619. (Pubitemid 32625431)
51. Ji L, Zhang G, Hirabayashi Y. 1995. Inhibition of tumor necrosis factor alpha- and ceramide-induced internucleosomal DNA fragmentation by herbimycin A in U937 cells. Biochem Biophys Res Commun 212: 640-647.
52. Kakeya H, Zhang HP, Kobinata K, Onose R, Onozawa C, Kudo T, Osada H. 1997. Cytotrienin A, a novel apoptosis inducer in human leukemia HL-60 cells. J Antibiot (Tokyo) 50: 370-372. (Pubitemid 27223133)
53. Yamashita N, Shin YK, Furihata K, Hayakawa Y, Seto H. 1998. New ravidomycin analogues, FE35A and FE35B, apoptosis inducers produced by Streptomyces rochei. J Antibiot (Tokyo) 51: 1105-1108. (Pubitemid 29054242)
54. Miura M, Zhu H, Rotello R, Hartweig EA, Yuan J. 1993. Induction of apoptosis in fibroblast by Il-1 beta converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-660. (Pubitemid 23346364)
55. Earnshaw WC, Martins LM, Kaufmann SH. 1999. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424. (Pubitemid 29449198)
56. Yuan J, Murrell GA, Trickett A, Wang MX. 2003. Involvement of cytochrome c release and caspase-3 activation in the oxidative stress-induced apoptosis in human tendon fibroblasts. Biochim Biophys Acta 1641: 35-41. (Pubitemid 36638707)
57. Debatin KM. 2004. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 53: 153-159.
58. Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T. 2002. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular- level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 50: 343-352.
59. Barnhart BC, Alappat EC, Peter ME. 2003. The CD95 type I/type II model. Semin Immunol 15: 185-193. (Pubitemid 38155825)
60. Boatright KM, Salvesen GS. 2003. Mechanisms of caspase activation. Curr Opin Cell Biol 15: 725-731. (Pubitemid 37492933)
61. Fan TJ, Han LH, Cong RS, Lizng J. 2005. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 37: 719-727.
62. Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619. (Pubitemid 23259742)